Study of blood level of lifesaving antibiotic meropenum in serious ICU patients in relation to blood level that kills bacteria.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- critically ill patients in IC
- Registration Number
- CTRI/2013/07/003850
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
Inclusion criteria
•Adult critically ill patients
•Age 18 yr to 70 yrs
•Known or suspected sepsis.
•Baseline plasma creatinine concentration within upper limit of normal
•Meropenem (MEROMER®) therapy initiated in ICU and expected to be continued for at least 3 days
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method